Emirates Oncology Society shared a post on LinkedIn:
“Lung Cancer / Thoracic Maligancies Session at the 3rd Best of ASTRO Gulf 2026 highlighted cutting – edge advances shaping contemporary management of thoracic malignancies.
Moderated by Dr. Eter Natelauri and Dr. Faiz Alshafa, the session featured expert perspectives from Dr. Ahmad Bushehri, Prof. Ugur Selek, and Dr. Bassem Youssef, highlighting collaborative, evidence – based approaches in contemporary lung cancer care.
Discussions focused on patient – reported outcomes from chemoradiation with or without immunotherapy in limited – stage small cell lung cancer, ten – year outcomes from the revised STARS trial comparing radiation and surgery in early – stage non – small cell lung cancer, and optimized thoracic radiotherapy strategies combined with systemic therapy for elderly or frail patients with stage III disease.
A high – impact session underscoring the importance of precision radiotherapy, integration of immunotherapy, and patient – centered outcomes in improving care for patients with thoracic malignancies.
Endorsed by: The Emirates Oncology Society and Emirates Radiation Oncology Working Group
Managed by Conveners”
More posts featuring Emirates Oncology Society
